Filing Details

Accession Number:
0001209191-16-104976
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2016-03-03 10:16:49
Reporting Period:
2015-09-28
Filing Date:
2016-03-03
Accepted Time:
2016-03-03 10:16:49
Original Submission Date:
2015-09-28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1344413 Alexza Pharmaceuticals Inc. ALXA Pharmaceutical Preparations (2834) 770567768
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1623398 Grupo Ferrer Internacional, S.a. Avenida Diagonal 549
5Th Floor
Barcelona U3 E-08029
No No Yes No
1668295 Sergio Ferrer-Salat Avenida Diagonal 549
5Th Floor
Barcelona U3 E-08029
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-09-28 125,000 $0.00 2,366,935 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The shares were issued as partial consideration for a term loan in the maximum principal amount of $5 million with an interest rate of 6% per annum from the Reporting Person to the Issuer as reported in Current Report on Form 8-K on the date hereof.
  2. Mr. Ferrer-Salat, as the Chairman and controlling shareholder of Grupo Ferrer Internacional S.A. ("Grupo Ferrer") may be deemed a beneficial owner of the securities held by Grupo Ferrer, but disclaims ownership thereof except to the extent of his pecuniary interest therein.